Intensive Care Patient Articles & Analysis: Older
8 news found
Particular support for decolonisation of pathogens which is the approach taken by its XF-73 Nasal programme Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today reports on the publication of findings from the US Food and Drug Administration (FDA) and US Centers for ...
N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. ...
The idea: Use of the antimicrobial and tissueregenerating effect of cold plasma in medicine and care with a small, handy device for stationary and mobile use. In 2019 the plasma care® was approved for the treatment of chronic wounds, in 2021 the plasma derma care® for the treatment of skin diseases induced by bacteria and fungi. The ...
Christon Hill, Vice President for Product Life Cycle Management, said: “There is an acute need for reliable rescue therapy for toxic methotrexate concentration in patients with delayed clearance due to impaired renal function. As we continue to achieve regulatory milestones that broaden the availability of glucarpidase globally, we grow more excited for Voraxaze’s ...
In less than two minutes, it allows doctors to assess how well a patient’s lungs are taking oxygen from the air through their lungs into the bloodstream,” says Dr. ...
The medical device enables rapid, repeatable, and trusted hemodynamic assessments throughout the continuum of care, including emergency department and intensive care unit patients with COVID-19. ...
She has specific experience in respiratory monitoring technologies and an education and clinical background in intensive care patient management. “We are delighted to welcome Laura Piccinini as RMI’s CEO” commented Chas Taylor, Chairman of RMI. ...
The foundation of our next generation system is an integrated artificial lung cartridge/blood pump that will be unparalleled in the industry as the most efficient carbon dioxide removal and oxygen delivery system, which will address the needs of acute respiratory failure patients that require ECCO2R and/or ECMO (extracorporeal membrane oxygenation). ...